AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Method for Preventing or Treating Enterochromaffin Cell Typerplasia-related Diseases by Quercetin Administration

Summary: It introduces a novel pharmacological use of Quercetin, which are abundantly presented in fruit, vegetables, herbs, and foodstuffs. It is effective in treating or preventing enterochromaffin (EC) cell hyperplasia-related diseases such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and irritable pouch syndrome (IPS)

Technology Benefits: Abundant in nature, effective and no toxicity

Technology Application: Prevent or treat enterochromatffin cell hyperplasia-related diseases such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and irritable pouch syndrome (IPS)

Detailed Technology Description: It provides methods and compositions for preventing or treating EC cell hyperplasia-related diseases. The compositions comprise a therapeutic effective amount of Quercetin, glycosylated Quercetin, or mixture thereof. The methods comprises administering said composition as well as preparing said composition as a pharmaceutical formulation.

Supplementary Information: Inventor: BIAN, Zhaoxiang | QIN, Hongyan | XIAO, Haitao | CHAN, Albert Sun-Chi | XU, Hongxi | CHEN, Shilin | YANG, Dajian
Priority Number: US20130210907A1
IPC Current: A61K0031353 | A23L000130
US Class: 514456 | 549400
Assignee Applicant: Hong Kong Baptist University
Title: METHOD FOR PREVENTING OR TREATING ENTEROCHROMAFFIN CELL HYPERPLASIA-RELATED DISEASES BY QUERCETIN ADMINISTRATION
Usefulness: METHOD FOR PREVENTING OR TREATING ENTEROCHROMAFFIN CELL HYPERPLASIA-RELATED DISEASES BY QUERCETIN ADMINISTRATION
Summary: For treatment or prevention of enterochromaffin cell hyperplasia-related diseases e.g. inflammatory bowel disease, irritable bowel syndrome, irritable pouch syndrome, post-infectious inflammatory bowel disease, post-infectious irritable bowel syndrome, post-infectious irritable pouch syndrome, untreated coeliac diseases, chronic gastritis of pernicious anaemia, hypergastrinemia-related diseases and gastrointestinal disorders induced by infections which occurs in mammal (claimed).

Industry: Biomedical

Sub Category: Medical Composition

Application Date: 2013.02.14

Application No.: US 13/767,865

Others: Published

ID No.: A61/BZ/Meth/US01

Country/Region: Hong Kong

For more information, please click Here